TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Price | 2.75p on 27-03-2025 | at 17:30:00
---|---|
Change | -0.175p -5.98% |
Buy | 2.80p |
Sell | 2.70p |
Buy / Sell EDEN Shares |
Last Trade: | Buy 8,000.00 at 2.90p |
Day's Volume: | 265,615 |
Last Close: | 2.75p |
Open: | 2.925p |
ISIN: | GB0001646941 |
Day's Range | 2.75p - 2.90p |
52wk Range: | 2.75p - 5.15p |
Market Capitalisation: | £15m |
VWAP: | 2.807356p |
Shares in Issue: | 533m |
Sector: Industrial Chemicals
Listed In: FTSE AIM All-Share,
Eden (EDEN) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 8,000 | 2.90p | Suspected BUY Trade |
14:00:01 - 27-Mar-25 |
Sell* | 130,718 | 2.75p | Ordinary |
13:26:01 - 27-Mar-25 |
Sell* | 100,000 | 2.85p | Ordinary |
09:24:59 - 27-Mar-25 |
Sell* | 15,897 | 2.90p | Ordinary |
09:02:35 - 27-Mar-25 |
Sell* | 11,000 | 2.90p | Ordinary |
08:18:30 - 27-Mar-25 |
Sell* | 15,878 | 2.85p | Ordinary |
15:27:42 - 26-Mar-25 |
Sell* | 32,284 | 2.85p | Ordinary |
11:18:58 - 26-Mar-25 |
Sell* | 828 | 2.90p | Ordinary |
11:14:27 - 26-Mar-25 |
Sell* | 20,000 | 2.85p | Ordinary |
10:04:58 - 26-Mar-25 |
Sell* | 10,000 | 2.85p | Ordinary |
09:13:43 - 26-Mar-25 |
Eden (EDEN) Regulatory News |
||
Date | Source | Headline |
---|---|---|
24th Mar 2025 7:00 am | RNS | Appointment of Distribution Partner in Kenya |
10th Mar 2025 7:00 am | RNS | Appointment of Joint Broker |
5th Mar 2025 12:52 pm | RNS | Director/PDMR Shareholding |
5th Mar 2025 7:00 am | RNS | Director/PDMR Shareholding |
4th Mar 2025 2:13 pm | RNS | Director/PDMR Shareholdings |
6th Feb 2025 2:08 pm | RNS | Director/PDMR Shareholding |
5th Feb 2025 7:00 am | RNS-R | Investor Presentation via Investor Meet Company |
28th Jan 2025 10:36 am | RNS | Director/PDMR Shareholdings |
13th Jan 2025 7:12 am | RNS | Trading Update |
20th Dec 2024 7:00 am | RNS | Regulatory approval for Novellus+ in Mexico |